AMIN NEZAMI, M.D. received his MD/Doctor of Medicine Degree from Tehran Medical I. Azad University in Iran in 1996. He completed his Residency in Family and Community Medicine at the University of California, San Francisco and an Internship in the Department of Surgery at the University California, Los Angeles. He is Board Certified in Family Medicine by the American Board of Fmily Medicine and he has been trained in Integrative Cancer Therapies, and is a Fellow and Diplomat with the American Academy of Anti-Aging and Regenerative Medicine.
He is an inventor of a new method of treating patients with a variety of cancers, both solid tumors and hematological cancers using natural substances, called MTET of multi-molecular targeted Epigenetic Therapy. Through this new method he has successfully treated patients with advanced cancer who have failed all other methods of conventional treatments. In collaboration with leading Oncology establishments in the academic settings, his method is on its way for broad spectrum clinical trials. His case stories have also been reviewed for best case series of Alternative and Complementary Medicine in oncology by the National Cancer Institute (NCI).
He is one of the Principal investigators commissioned by the National Institute of Health for the TACT Trial (Trial to Assess Chelation Therapy). His practice encompasses Integrative Oncology, Genetic Testing and Cancer Prevention and Treatment. His main area of research and interest is cancer stem cells and Epigenetic Plasticity And Differentiation Therapies.
Since 2008, he has been the Medical Director and President of Pacific Medical Center of Hope, in Fresno, California. This center has welcomed patients traveling from all over the US and as well as Europe. The second franchised center of his practice is opening in September 2013, in Newport Beach, California. He may be contacted through his Clinic by phone 559-475-4300. Please review his success stories on his website www.allcancercare.com.
Dr. Nezami will speak on Modified Targeted Epigenetic Therapy (MTET).